Abstract
Introduction
Materials and Methods
Results
Conclusions
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe toReferences
- Complications after lumbar spine surgery between teaching and nonteaching hospitals.Spine. 2014; 39: 417-423
- Current trends in demographics, practice, and in-hospital outcomes in cervical spine surgery: a national database analysis between 2002 and 2011.Spine. 2014; 39: 476-481
- Persistent spinal pain syndrome: a proposal for failed back surgery syndrome and ICD-11.Pain Med. 2021; 22: 807-818
- Evidence gaps in the use of spinal cord stimulation for treating chronic spine conditions.Spine. 2017; 42: S80-S92
- Paddle lead cervical spinal cord stimulation for failed neck surgery syndrome.Clin Neurol Neurosurg. 2013; 115: 2254-2256
- Spinal cord stimulation for complex regional pain syndrome: a systematic review of the clinical and cost-effectiveness literature and assessment of prognostic factors.Eur J Pain. 2006; 10: 91-101
- Spinal cord stimulation provides pain relief with improved psychosocial function: results from EMP3OWER.Pain Med. 2016; 17: 2311-2325
- Results from the partnership for advancement in neuromodulation registry: a 24-month follow-up.Neuromodulation. 2016; 19: 179-187
- Electrical stimulation of the cervical spinal cord increases cerebral blood flow in humans.Appl Neurophysiol. 1985; 48: 372-376
- Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger’s disease).J Vasc Surg. 1999; 29: 928-935
- Cervicomedullary junction spinal cord stimulation for head and facial pain.Headache. 2011; 51: 418-425
- Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study.Brain. 2004; 127: 220-230
- Cervical spinal cord stimulation for the management of pain from brachial plexus avulsion.Pain Med. 2014; 15: 712-714
- The beneficial effect of spinal cord stimulation in a patient with severe cerebral ischemia and upper extremity ischemic pain.Pain Pract. 2007; 7: 135-142https://doi.org/10.1111/j.1533-2500.2007.00121.x
- The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee.Neuromodulation. 2014; 17 ([discussion: 550]): 515-550https://doi.org/10.1111/ner.12208
- The Neurostimulation Appropriateness Consensus Committee (NACC) safety guidelines for the reduction of severe neurological injury.Neuromodulation. 2017; 20: 15-30
- The Neurostimulation Appropriateness Consensus Committee (NACC) recommendations for infection prevention and management.Neuromodulation. 2017; 20: 31-50
- The Neurostimulation Appropriateness Consensus Committee (NACC): recommendations on bleeding and coagulation management in neurostimulation devices.Neuromodulation. 2017; 20: 51-62
- The Polyanalgesic Consensus Conference (PACC): recommendations for trialing of intrathecal drug delivery infusion therapy.Neuromodulation. 2017; 20: 133-154
- The Polyanalgesic Consensus Conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines.Neuromodulation. 2017; 20: 96-132
- The Polyanalgesic Consensus Conference (PACC): recommendations for intrathecal drug delivery: guidance for improving safety and mitigating risks.Neuromodulation. 2017; 20: 155-176
- Current methods of the US Preventive Services Task Force: a review of the process.Am J Prev Med. 2001; 20: 21-35
- Effectiveness of cervical spinal cord stimulation for the management of chronic pain.Neuromodulation. 2014; 17: 265-271
- Cervical spinal cord stimulation for pain: a report on 41 patients.Neuromodulation. 2003; 6: 20-26
- C1-C2 sublaminar insertion of paddle leads for the management of chronic painful conditions of the upper extremity.Neuromodulation. 2003; 6: 153-157
- Cervical and cervicomedullary spinal cord stimulation for chronic pain: efficacy and outcomes.Clin Neurol Neurosurg. 2014; 127: 33-41
- Upper cervical spinal cord stimulation as an alternative treatment in trigeminal neuropathy.World Neurosurg. 2018; 114: e641-e646
- High cervical spinal cord stimulation for occipital neuralgia: a case series and literature review.J Pain Res. 2019; 12: 2547-2553
- Spinal cord stimulation for relief of chronic pain in vasospastic disorders of the upper limbs.Neurosurgery. 1989; 24: 63-67
- Neuromodulation of the cervical spinal cord in the treatment of chronic intractable neck and upper extremity pain: a case series and review of the literature.Pain Physician. 2007; 10: 305-311
- High cervical spinal cord stimulation for chronic cluster headache.Cephalalgia. 2011; 31: 1170-1180
- The use of 10-kilohertz spinal cord stimulation in a cohort of patients with chronic neuropathic limb pain refractory to medical management.Neuromodulation. 2015; 18: 18-23https://doi.org/10.1111/ner.12237
- High-cervical spinal cord stimulation for medically intractable chronic migraine.Neuromodulation. 2015; 18: 289-296
- Safety and efficacy of cervical 10 kHz spinal cord stimulation in chronic refractory primary headaches: a retrospective case series.J Headache Pain. 2016; 17: 66
- 10 kHz cervical SCS for chronic neck and upper limb pain: 12 months’ results.Ann Clin Transl Neurol. 2019; 6: 2223-2229
- High cervical spinal cord stimulation: a one year follow-up study on motor and non-motor functions in Parkinson’s disease.Brain Sci. 2019; 9: 78
- Retrospective analysis of real-world outcomes of 10 kHz SCS in patients with upper limb and neck pain.J Pain Res. 2020; 13: 1441-1448
- Spinal cord stimulation in the treatment of spasmodic torticollis.Appl Neurophysiol. 1985; 48: 324-338
- The use of high-dose cervical spinal cord stimulation in the treatment of chronic upper extremity and neck pain.Surg Neurol Int. 2020; 10: 1-3
- A single center prospective observational study of outcomes with tonic cervical spinal cord stimulation.Neuromodulation. 2017; 20: 263-268
- Cervical 10 kHz spinal cord stimulation in the management of chronic, medically refractory migraine: a prospective, open-label, exploratory study.Eur J Pain. 2016; 20: 70-78
- Spinal cord stimulation for the treatment of failed neck surgery syndrome: outcome of a prospective case series.Neuromodulation. 2018; 21: 495-503
- 10 kHz spinal cord stimulation for chronic upper limb and neck pain: Australian experience.Eur Spine J. 2020; 29: 2786-2794
- Cervical spinal cord stimulation using monophasic burst waveform for axial neck and upper extremity radicular pain: a preliminary observational study.Neuromodulation. 2020; 23: 680-686
- High-frequency spinal cord stimulation at 10 kHz for the treatment of combined neck and arm pain: results from a prospective multicenter study.Neurosurgery. 2020; 87: 176-185
- Treatment of chronic pain with spinal cord stimulation versus alternative therapies: cost-effectiveness analysis.Neurosurgery. 2002; 51: 106-115
- Novel 10-kHz high-frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain: the SENZA-RCT randomized controlled trial.Anesthesiology. 2015; 123: 851-860
- Prevention of percutaneous spinal cord stimulation electrode migration: a 15-year experience.Neuromodulation. 2014; 17: 670-676
US Department of Health and Human Services. Pain management best practices inter-agency task force report: updates, gaps, inconsistencies, and recommendations; May 2019. Accessed May 25, 2021. https://www.hhs.gov/ash/advisory-committees/pain/reports/index.html
- Spinal cord stimulation is effective in management of complex regional pain syndrome I: fact or fiction.Neurosurgery. 2011; 69: 566-578
- Applied epidural anatomy.Contin Educ Anaesth Crit Care Pain. 2005; 5: 98-100https://doi.org/10.1093/bjaceaccp/mki026
- Distribution of solution in the epidural space: examination by cryomicrotome section.Reg Anesth Pain Med. 2002; 27: 150-156https://doi.org/10.1053/rapm.2002.29748
- The cervical myodural bridge, a review of literature and clinical implications.J Can Chiropr Assoc. 2014; 58: 184-192
- Investigation of human cervical and upper thoracic spinal cord motion: implications for imaging spinal cord structure and function.Magn Reson Med. 2007; 58: 185-189https://doi.org/10.1002/mrm.21260
- Epidural Analgesia—Current Views and Approaches.InTech Open, 2012https://doi.org/10.5772/2167
- Magnetic resonance imaging of the extradural space of the thoracic spine.Br J Anaesth. 1997; 79: 563-566https://doi.org/10.1093/bja/79.5.563
- Complications of spinal cord stimulation and peripheral nerve stimulation techniques: a review of the literature.Pain Med. 2016; 17: 325-336
- Rate of perioperative neurological complications after surgery for cervical spinal cord stimulation.J Neurosurg Spine. 2016; 25: 31-38
- Incidence of clinically significant percutaneous spinal cord stimulator lead migration.Neuromodulation. 2015; 18: 123-125
- Novel technique for insertion of cervical spinal cord stimulator percutaneous leads: technical note and institutional experience.World Neurosurg. 2018; 119: 118-122
- Spinal cord injury induced by a cervical spinal cord stimulator.Neuromodulation. 2011; 14: 34-36
- MR assessment of the normal position of the spinal cord in the spinal canal.AJNR Am J Neuroradiol. 1994; 15: 951-959
- The relationship between the cervical spinal canal diameter and the pathological changes in the cervical spine.Eur Spine J. 2009; 18: 877-883https://doi.org/10.1007/s00586-009-0968-y
- A novel nonanchoring technique for implantation of paddle leads in the cervical spine with conscious sedation.Neuromodulation. 2015; 18: 472-477https://doi.org/10.1111/ner.12283
- Comparison of paresthesia coverage of patient's pain: dorsal root ganglion vs. spinal cord stimulation. An ACCURATE study sub-analysis.Neuromodulation. 2019; 22: 930-936
- Dorsal root ganglion stimulation is paresthesia-independent: a retrospective study.Neuromodulation. 2019; 22: 937-942
- Single S1 dorsal root ganglia stimulation for intractable complex regional pain syndrome foot pain after lumbar spine surgery: a case series.Neuromodulation. 2019; 22: 101-107
- The pathways and processes underlying spinal transmission of low back pain: observations from dorsal root ganglion stimulation treatment.Neuromodulation. 2021; 24: 610-621https://doi.org/10.1111/ner.13150
- Cervical and high-thoracic dorsal root ganglion stimulation in chronic neuropathic pain.Neuromodulation. 2019; 22: 951-955
- Dorsal root ganglion stimulation (DRGS) for the treatment of chronic neuropathic pain: a single-center study with long-term prospective results in 62 cases.Pain Physician. 2018; 21: E377-E387
- Three-year outcomes after dorsal root ganglion stimulation in the treatment of neuropathic pain after peripheral nerve injury of upper and lower extremities.Neuromodulation. 2021; 24: 700-707
- Objective improvements in peripheral arterial disease from dorsal root ganglion stimulation: a case series.Ann Vasc Surg. 2021; 74 (519.e7–519.e16)https://doi.org/10.1016/j.avsg.2021.01.069
- The Neurostimulation Appropriateness Consensus Committee (NACC) recommendations for the mitigation of complications of neurostimulation.Neuromodulation. 2021;
Centers for Disease Control and Prevention. Guidelines Library. Updated February 28, 2017. Accessed May 5, 2021. https://www.cdc.gov/infectioncontrol/guidelines/index.htm
- Spinal cord stimulator related infections: findings from a multicenter retrospective analysis of 2737 implants.Neuromodulation. 2017; 20: 553-557https://doi.org/10.1111/ner.12636
- Incidence of revision surgery in a large cohort of patients with thoracic surgical three-column paddle leads: a retrospective case review.Neuromodulation. 2015; 18: 367-375https://doi.org/10.1111/ner.12239
- Care bundle approach to minimizing infection rates after neurosurgical implants for neuromodulation: a single-surgeon experience.World Neurosurg. 2019; 128: e87-e97https://doi.org/10.1016/j.wneu.2019.04.003
- Practice advisory for the prevention, diagnosis, and management of infectious complications associated with neuraxial techniques: an updated report by the American Society of Anesthesiologists Task Force on infectious complications associated with neuraxial techniques and the American Society of Regional Anesthesia and Pain Medicine.Anesthesiology. 2017; 126: 585-601
- Spinal cord stimulator infection: approach to diagnosis, management, and prevention.Clin Infect Dis. 2020; 70: 2727-2735
- Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications (second edition): guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain.Reg Anesth Pain Med. 2018; 43: 225-262
- The incidence of spinal cord injury in implantation of percutaneous and paddle electrodes for spinal cord stimulation.Neuromodulation. 2016; 19: 85-90
- Failure modes of spinal cord stimulation hardware.J Neurosurg Spine. 2006; 5: 183-190
- Retrospective review of 707 cases of spinal cord stimulation: indications and complications.Pain Pract. 2011; 11: 148-153
- Multicenter retrospective study of neurostimulation with exit of therapy by explant.Neuromodulation. 2017; 20: 543-552
- Pocket pain, does location matter: a single-centre retrospective study of patients implanted with a spinal cord stimulator.Reg Anesth Pain Med. 2020; 45: 891-897
- The Neurostimulation Appropriateness Consensus Committee (NACC) recommendations for therapy salvage and persistent outcome optimization.Neuromodulation. 2021;
- Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trial.Lancet Neurol. 2020; 19: 123-134
Comments
Article info
Publication history
Footnotes
Source(s) of financial support: This Neurostimulation Appropriateness Consensus Committee publication was supported by the International Neuromodulation Society, and no authors were paid for their contributions.
Conflict of Interest: Timothy R. Deer consults for Abbott, Saluda, Ethos, Nalu, Paintec, and Cornorloc; holds a patent pending with Abbott; is on the advisory board of Abbott and Nalu; has stock options from Saluda, Spinethera, and Nalu; and has institutional research grants from Abbott, Saluda, Vertiflex, and Mainstay. Jason Pope serves as a consultant, on the advisory board, and conducts research for Ethos Labs, Flowonix, Saluda, PainTeq, Aurora Spine, Thermaquil, Abbott, Vertiflex, Vertos, and SPARK; owns stock in PainTeq, Aurora Spine, Thermaquil, Spine Thera, AGR, NIS, Vertos, Celeri Health, and SPARK; receives royalties from Aurora Spine; consults for Medtronic, Boston Scientific, and WISE; conducts research for Celeri Health and Boston Scientific; and serves on the advisory board of Spine Thera. Jonathan M. Hagedorn receives consulting fees and serves on the advisory boards of Abbott, Boston Scientific, and Nevro. Jacqueline Weisbein reports personal fees from Abbott Medical, Medtronic, Boston Scientific, Saluda Medical, Omnia Medical, Vertos Medical, and PainTeq, outside the submitted work. Alaa Abd-Elsayed consults for Medtronic, Avanos, and StimWave. Ramsin Benyamin consults for Medtronic, Avanos, and Vertiflex and had a patent issued and then licensed to Medtronic as part of Stimgenics acquisition by Medtronic. No royalties are pending. Louis J. Raso serves as a consultant for Boston Scientific. Kiran V. Patel reports other from Abbott Neuromodulation, outside the submitted work. David Provenzano has consulted for Avanos, Boston Scientific, Esteve, Heron, Medtronic, and Nevro. He has received research support from Avanos, Medtronic, Nevro, Stimgenics, and Abbott. Philip S. Kim consults with Medtronic; consults, serves on the advisory board, and does research with Biotronik; does research with Abbott; has conducted research for Medtronic, Boston Scientific, and Stimgenics; owns stock from SGX International; and has leadership roles in the Pennsylvania Pain Society and the North American Neuromodulation Society. Kasra Amirdelfan reports grants and personal fees from Nevro, Biotronik, Saluda, Nalu, and personal fees from Medtronic, outside the submitted work. Richard Sullivan reports personal fees from Abbott, Medtronic, and Nevro and grants from Saluda, outside the submitted work. Paul Verrills reports grants and personal fees from Nalu, Abbott, and Biotronik and grants from Saluda and Presidio, outside the submitted work. Jon Carlson reports personal fees from Saluda Medical, Abbott, SPR Therapeutics, Nevro, and Boston Scientific-Vertiflex; other from Cornerloc and Pill Nurse, outside the submitted work. Leo Kapural consults with Nevro, Abbott, Medtronic, Nalu, Biotronik, and Stimgenics and conducts research for Saluda, Gimer, Nevro, and Biotronik. Sudhir Diwan reports other from Boston Scientific, CornerLoc, and IntraVu, outside the submitted work. Giancarlo Barolat reports personal fees from Medtronic, Boston Scientific, and Nuvectra, outside the submitted work. Alexander L. Green receives personal payments from Abbott for serving as faculty for Neuromodulation Fellowship Programme, teaching courses on dorsal root ganglion and spinal cord stimulation, and is on the Data Safety Monitoring Board for Renishaw plc/Herantis Pharma for a trial of intraputaminal CDNF for Parkinson disease. Fabian Piedimonte reports personal fees from Medtronic and Abbott, outside the submitted work, that were divested in May 2020. Nestor D. Tomycz consults and reports scientific research grants from Abbott. James FitzGerald reports research grants from Abbott, UCB, and Merck; personal consulting fees and speaking honoraria from Abbott; institutional fees from Medtronic, Renshaw; participation on a Data Safety Monitoring Board or Advisory Board for Herantis (Parkinson disease) and Medtronic (spinal cord stimulation); and is a board member of NSUKI. Kliment Gatzinsky receives consulting fees from Boston Scientific; payments or honoraria from Abbott, Boston Scientific, Medtronic, and Nevro; and participates on a Data Safety Monitoring Board or Advisory Board for Boston Scientific and Medtronic. Konstantin V. Slavin reports fellowship grants from Medtronic, Abbott, and Boston Scientific; research grants from Neuros, Medtronic, and Abbott; personal fees (consulting) from MSEI and Stimwave; other (minor ownership; stock or stock options) from Stimwave, Thermaquil, Neuramodix, Higgs Boson, and Vycor Medical, outside the submitted work. Robert M. Levy is an uncompensated consultant for Nalu, Saluda Medical, and Mainstay Medical and has stock options from Nalu and Saluda Medical obtained before 2019, not exercisable through the duration of his term as International Neuromodulation Society President and editor-in-chief of the journal, Neuromodulation: Technology at the Neural Interface. The remaining authors reported no conflict of interest.
Identification
Copyright
ScienceDirect
Access this article on ScienceDirectLinked Article
- ErratumNeuromodulationVol. 25Issue 3
- PreviewWith regard to the article in the January 2022 issue entitled “The Neurostimulation Appropriateness Consensus Committee (NACC): Recommendations on Best Practices for Cervical Neurostimulation” (Neuromodulation 2022;25(1):35-52), the 27th author’s name was listed incorrectly. It should be “Miguel D. Attias, MD.” The authors regret the error.
- Full-Text
- Preview
